AR and acute myeloid leukemia: To address whether IL-6 might upregulate AR in AML we measured the level of IL-6 in BM ‘plasma’ samples collected from 47 AML patients (European LeukemiaNet; ELN 2022 risk: 8 favorable; 16 intermediate; 23 adverse) and 17 age-matched controls.